Martin Bögemann Selected Research

Martin Bögemann Research Topics

Disease

47	Prostatic Neoplasms (Prostate Cancer) 05/2024 - 01/2006
16	Neoplasm Metastasis (Metastasis) 12/2023 - 12/2015
15	Neoplasms (Cancer) 05/2024 - 01/2006
5	Renal Cell Carcinoma (Grawitz Tumor) 02/2024 - 06/2007
5	Carcinoma (Carcinomatosis) 01/2023 - 12/2016
3	Circulating Neoplastic Cells 01/2022 - 01/2016
1	Pain (Aches) 01/2023
1	Hypertension (High Blood Pressure) 01/2023
1	Body Weight (Weight, Body) 01/2023
1	Hand-Foot Syndrome 06/2022
1	Urogenital Neoplasms 06/2022
1	Fever (Fevers) 06/2022
1	Kidney Neoplasms (Kidney Cancer) 01/2022
1	Hepatitis 12/2020
1	Drug-Related Side Effects and Adverse Reactions 12/2020
1	Acute Kidney Injury (Acute Renal Failure) 12/2020
1	Acute Liver Failure (Fulminant Hepatic Failure) 12/2020
1	Neutropenia 12/2020
1	Septic Shock (Toxic Shock Syndrome) 12/2020
1	Pneumonia (Pneumonitis) 12/2020
1	Thyroid Neoplasms (Thyroid Cancer) 02/2018
1	Sarcoma (Soft Tissue Sarcoma) 01/2017
1	Fatigue 01/2016
1	Anemia 01/2016
1	Cancer Pain 01/2016
1	Urinary Bladder Neoplasms (Bladder Cancer) 07/2007
1	Ovarian Neoplasms (Ovarian Cancer) 01/2006
1	Breast Neoplasms (Breast Cancer) 01/2006

Drug/Important Bio-Agent (IBA)

14	AntigensIBA 01/2023 - 01/2013
8	AndrogensIBA 04/2024 - 01/2018
8	Prostate-Specific Antigen (Semenogelase)IBA 04/2024 - 11/2014
7	Androgen Receptors (Androgen Receptor)IBA 05/2024 - 01/2018
6	177Lu-PSMA-617IBA 07/2021 - 07/2016
5	Hormones (Hormone)IBA 04/2024 - 12/2015
5	darolutamideIBA 04/2024 - 01/2023
5	LigandsIBA 10/2022 - 02/2017
4	Docetaxel (Taxotere)FDA Link 04/2024 - 12/2020
4	Biomarkers (Surrogate Marker)IBA 04/2023 - 01/2016
4	gallium 68 PSMA-11IBA 07/2021 - 04/2016
3	Tyrosine Kinase InhibitorsIBA 02/2024 - 06/2022
3	apalutamideIBA 12/2023 - 02/2022
2	RadiopharmaceuticalsIBA 05/2024 - 11/2021
2	enzalutamideIBA 01/2023 - 01/2022
2	Prednisone (Sone)FDA LinkGeneric 01/2022 - 12/2020
2	PSMA-617IBA 07/2021 - 01/2017
2	PlatinumIBA 12/2020 - 01/2015
2	Messenger RNA (mRNA)IBA 01/2020 - 01/2018
2	Protein Isoforms (Isoforms)IBA 01/2019 - 11/2014
2	Endothelins (Endothelin)IBA 07/2007 - 01/2006
1	TransposasesIBA 05/2024
1	Sunitinib (Sutent)FDA Link 02/2024
1	Antineoplastic Agents (Antineoplastics)IBA 10/2023
1	Complement System Proteins (Complement)IBA 01/2022
1	SteroidsIBA 01/2022
1	NivolumabIBA 01/2022
1	pembrolizumabIBA 01/2022
1	abirateroneIBA 01/2022
1	Testosterone (Sustanon)FDA Link 01/2021
1	durvalumabIBA 12/2020
1	tremelimumabIBA 12/2020
1	Abiraterone AcetateIBA 12/2020
1	Immune Checkpoint InhibitorsIBA 12/2020
1	Opioid Analgesics (Opioids)IBA 12/2020
1	Cisplatin (Platino)FDA LinkGeneric 12/2020
1	Lipase (Acid Lipase)FDA Link 12/2020
1	Prednisolone (Predate)FDA LinkGeneric 12/2020
1	Fluorine-18IBA 07/2020
1	taxaneIBA 10/2019
1	Radioisotopes (Radionuclides)IBA 06/2019
1	pazopanib FDA Link 01/2019
1	Sorafenib (BAY 43-9006)FDA Link 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2018
1	Epithelial Cell Adhesion MoleculeIBA 10/2017
1	MineralsIBA 02/2017
1	LutetiumIBA 02/2017
1	Alkaline PhosphataseIBA 01/2017
1	radium Ra 223 dichlorideIBA 12/2016
1	tasquinimodIBA 01/2016
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2016
1	cabozantinibIBA 01/2016
1	Phosphotransferases (Kinase)IBA 01/2016
1	Everolimus FDA Link 01/2015
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2015
1	Serine Proteases (Serine Protease)IBA 01/2013
1	AntibodiesIBA 07/2007
1	Endothelin-1 (Endothelin 1)IBA 07/2007
1	ParaffinIBA 07/2007
1	Fluorouracil (Carac)FDA LinkGeneric 06/2007
1	Interleukin-2 (IL2)IBA 06/2007
1	Interferon-alpha (Interferon Alfa)IBA 06/2007
1	AtrasentanIBA 01/2006

Therapy/Procedure

35	Therapeutics 05/2024 - 06/2007
32	Castration 05/2024 - 01/2016
9	Drug Therapy (Chemotherapy) 01/2023 - 01/2015
4	Prostatectomy (Retropubic Prostatectomy) 05/2024 - 11/2014
1	Immunotherapy 08/2023
1	Neoadjuvant Therapy 01/2021
1	Orchiectomy (Orchidectomy) 01/2021
1	Cystectomy 07/2007
1	Molecular Targeted Therapy 01/2006